Literature DB >> 18173228

Statistical analysis of the effects of common chemical substituents on ligand potency.

Philip J Hajduk1, Daryl R Sauer.   

Abstract

The results of a statistical analysis of more than 84,000 compounds from lead optimization programs against 30 different protein targets is presented, with a focus on the effects that different chemical substituents have on compound potency. It is observed that the potency changes induced by most chemical groups follows a nearly normal distribution centered near zero (i.e., no effect on potency). However, the widths of the distributions vary significantly between different substituents, and these effects cannot be rationalized by simple physicochemical parameters. In addition, certain substituents consistently bias the distribution toward higher or lower potency, suggesting the existence of preferred and nonpreferred chemical groups for lead optimization. The implications of these results for understanding protein-ligand recognition and for enhancing the efficiency and speed of lead optimization will be discussed.

Mesh:

Substances:

Year:  2008        PMID: 18173228     DOI: 10.1021/jm070838y

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Successful identification of key chemical structure modifications that lead to improved ADME profiles.

Authors:  Lourdes Cucurull-Sanchez
Journal:  J Comput Aided Mol Des       Date:  2010-05-09       Impact factor: 3.686

Review 2.  Chemical predictive modelling to improve compound quality.

Authors:  John G Cumming; Andrew M Davis; Sorel Muresan; Markus Haeberlein; Hongming Chen
Journal:  Nat Rev Drug Discov       Date:  2013-12       Impact factor: 84.694

3.  Intramolecular Hydrogen Bond Expectations in Medicinal Chemistry.

Authors:  Fabrizio Giordanetto; Christian Tyrchan; Johan Ulander
Journal:  ACS Med Chem Lett       Date:  2017-01-18       Impact factor: 4.345

4.  The use of matched molecular series networks for cross target structure activity relationship translation and potency prediction.

Authors:  Christopher E Keefer; George Chang
Journal:  Medchemcomm       Date:  2017-10-11       Impact factor: 3.597

5.  Perspective: Alchemical free energy calculations for drug discovery.

Authors:  David L Mobley; Pavel V Klimovich
Journal:  J Chem Phys       Date:  2012-12-21       Impact factor: 3.488

6.  Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy.

Authors:  Kevin J Frankowski; Michael P Hedrick; Palak Gosalia; Kelin Li; Shenghua Shi; David Whipple; Partha Ghosh; Thomas E Prisinzano; Frank J Schoenen; Ying Su; S Vasile; Eduard Sergienko; Wilson Gray; Santosh Hariharan; Loribelle Milan; Susanne Heynen-Genel; Arianna Mangravita-Novo; Michael Vicchiarelli; Layton H Smith; John M Streicher; Marc G Caron; Lawrence S Barak; Laura M Bohn; Thomas D Y Chung; Jeffrey Aubé
Journal:  ACS Chem Neurosci       Date:  2012-01-20       Impact factor: 4.418

7.  Nexus between protein-ligand affinity rank-ordering, biophysical approaches, and drug discovery.

Authors:  M Ashley Spies
Journal:  ACS Med Chem Lett       Date:  2013-09-19       Impact factor: 4.345

8.  Chemical transformations that yield compounds with distinct activity profiles.

Authors:  Ye Hu; Jürgen Bajorath
Journal:  ACS Med Chem Lett       Date:  2011-04-13       Impact factor: 4.345

9.  FGFR1 Kinase Inhibitors: Close Regioisomers Adopt Divergent Binding Modes and Display Distinct Biophysical Signatures.

Authors:  Tobias Klein; Julie Tucker; Geoffrey A Holdgate; Richard A Norman; Alexander L Breeze
Journal:  ACS Med Chem Lett       Date:  2013-12-06       Impact factor: 4.345

10.  Exploring Structure-Activity Data Using the Landscape Paradigm.

Authors:  Rajarshi Guha
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2012-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.